Tiziana Life Sciences (TLSA) has received a notice from Nasdaq stating that the company is not in compliance with the $1.00 Minimum Bid Price Requirement for continued listing. The company has until January 16, 2024, to regain compliance by having the closing bid price of its shares meet or exceed $1.00 for at least ten consecutive business days. The notice is not of imminent delisting and Tiziana intends to resolve the deficiency.